Formulation Development Solutions

  1. Peptide CDMO Services 3/11/2026

    Learn how peptide‑synthesis platforms, early impurity control, and optimized downstream methods boost scalability, stability, and development speed from early design to late‑stage readiness.

  2. Adare Pharma Solutions (APS) Orbis Overview 10/27/2020

    Orbis provides innovative taste-making and controlled release solutions for oral and injectable pharmaceutical products.

  3. Gibco Efficient-Pro Medium And Feeds Evaluation Guide 6/9/2025

    Discover a high-performing solution for mAb production designed to significantly improve titers, cell viability, and protein quality in CHO cell lines.

  4. Arc HPLC 10/7/2022

    Learn how you can remove the burden of your aging HPLC workhorses by trading up to a new Waters Arc HPLC.

  5. Picoliter Dispensing Redefined, Now For Single Cells Too 11/7/2025

    Accelerate single-cell and low-volume workflows with high precision, fast setup, and surfactant-free dispensing that delivers reproducible results and flexible performance across cell types and reagents.

  6. High Potency Handling Capabilities And Support 10/15/2025

    Highly potent APIs require stringent containment and precise manufacturing controls. Specialized facilities offer end-to-end development solutions and robust cross-contamination protections.

  7. Comprehensive Support For Regulated Laboratories With FlexCHOICE Service Coverage 4/11/2022

    With Waters FlexCHOICE: mySystem Coverage Solutions you’ll have access to all the service, support, and performance maintenance options you need to ensure uninterrupted performance and more control over your service and maintenance costs.

  8. A Technology-Driven CDMO Delivering Integrated End-To-End Services

    Explore this interactive PDF with information about technologies & end-to-end integrated CDMO services provided by Adare Pharma Solutions.

  9. A High-Purity Excipient Suitable For High-Risk Vaccine Applications 7/21/2025

    Examine an ultra-pure, sustainable alternative to shark-derived squalene. With ≥99% purity, it ensures safety, consistency, and ethical sourcing for innovation.

  10. Resin Offering High Productivity And Robust Processes 5/3/2023

    MabSelect™ VL affinity resin uses a protein L ligand with strong affinity for the variable region of a human antibody’s kappa light chain. The resin offers high productivity and robust processes for affinity capture of bispecific antibodies and antibody fragments containing the kappa light chain and offers a good capture alternative for antibody variants that does not bind to protein A.